ANSYS Statistics
Total Valuation
ICU Medical has a market cap or net worth of $3.14 billion. The enterprise value is $4.44 billion.
Important Dates
The next confirmed earnings date is Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU Medical has 24.61 million shares outstanding. The number of shares has increased by 1.34% in one year.
| Current Share Class | 24.61M |
| Shares Outstanding | 24.61M |
| Shares Change (YoY) | +1.34% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 1.14% |
| Owned by Institutions (%) | 101.53% |
| Float | 23.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 18.56 |
| PS Ratio | 1.29 |
| Forward PS | 1.45 |
| PB Ratio | 1.58 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 23.85 |
| P/OCF Ratio | 14.96 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 13.26, with an EV/FCF ratio of 33.76.
| EV / Earnings | n/a |
| EV / Sales | 1.83 |
| EV / EBITDA | 13.26 |
| EV / EBIT | 36.61 |
| EV / FCF | 33.76 |
Financial Position
The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.81.
| Current Ratio | 2.59 |
| Quick Ratio | 0.87 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 4.50 |
| Debt / FCF | 12.18 |
| Interest Coverage | 1.15 |
Financial Efficiency
Return on equity (ROE) is -4.62% and return on invested capital (ROIC) is 2.06%.
| Return on Equity (ROE) | -4.62% |
| Return on Assets (ROA) | 1.79% |
| Return on Invested Capital (ROIC) | 2.06% |
| Return on Capital Employed (ROCE) | 3.33% |
| Revenue Per Employee | $161,340 |
| Profits Per Employee | -$6,246 |
| Employee Count | 15,000 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 2.45 |
Taxes
In the past 12 months, ICU Medical has paid $53.54 million in taxes.
| Income Tax | 53.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.33% in the last 52 weeks. The beta is 0.88, so ICU Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | +0.33% |
| 50-Day Moving Average | 130.58 |
| 200-Day Moving Average | 149.54 |
| Relative Strength Index (RSI) | 46.81 |
| Average Volume (20 Days) | 192,810 |
Short Selling Information
The latest short interest is 1.18 million, so 4.81% of the outstanding shares have been sold short.
| Short Interest | 1.18M |
| Short Previous Month | 1.36M |
| Short % of Shares Out | 4.81% |
| Short % of Float | 4.97% |
| Short Ratio (days to cover) | 5.25 |
Income Statement
In the last 12 months, ICU Medical had revenue of $2.42 billion and -$93.69 million in losses. Loss per share was -$3.83.
| Revenue | 2.42B |
| Gross Profit | 849.65M |
| Operating Income | 121.25M |
| Pretax Income | -98.35M |
| Net Income | -93.69M |
| EBITDA | 334.68M |
| EBIT | 121.25M |
| Loss Per Share | -$3.83 |
Full Income StatementBalance Sheet
The company has $298.11 million in cash and $1.60 billion in debt, giving a net cash position of -$1.30 billion or -$52.96 per share.
| Cash & Cash Equivalents | 298.11M |
| Total Debt | 1.60B |
| Net Cash | -1.30B |
| Net Cash Per Share | -$52.96 |
| Equity (Book Value) | 1.99B |
| Book Value Per Share | 80.76 |
| Working Capital | 874.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $209.57 million and capital expenditures -$78.08 million, giving a free cash flow of $131.49 million.
| Operating Cash Flow | 209.57M |
| Capital Expenditures | -78.08M |
| Free Cash Flow | 131.49M |
| FCF Per Share | $5.34 |
Full Cash Flow StatementMargins
Gross margin is 35.11%, with operating and profit margins of 5.01% and -3.87%.
| Gross Margin | 35.11% |
| Operating Margin | 5.01% |
| Pretax Margin | -1.66% |
| Profit Margin | -3.87% |
| EBITDA Margin | 13.83% |
| EBIT Margin | 5.01% |
| FCF Margin | 5.43% |
Dividends & Yields
ICU Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.34% |
| Shareholder Yield | -1.34% |
| Earnings Yield | -2.99% |
| FCF Yield | 4.19% |
Dividend DetailsAnalyst Forecast
The average price target for ICU Medical is $196.75, which is 54.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $196.75 |
| Price Target Difference | 54.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 2.55% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 18, 2002. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Mar 18, 2002 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
ICU Medical has an Altman Z-Score of 2.11 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.11 |
| Piotroski F-Score | 6 |
